Literature DB >> 6310442

Inclusion body myositis (IBM): myopathy or neuropathy?

A Eisen, K Berry, G Gibson.   

Abstract

Inclusion body myositis (IBM) is described in six elderly patients (three women) and in a young familial patient. They all showed the morphologically characteristic vacuoles containing osmiophilic membranous whorls and intracytoplasmic or intranuclear inclusions. There is a well-delineated bimodal age spectrum of IBM, with onset in the second and sixth decades, but otherwise the disorder seems to be a specific entity. Clinical, electrophysiologic, and morphologic features suggest a neurogenic origin in some cases.

Entities:  

Mesh:

Year:  1983        PMID: 6310442     DOI: 10.1212/wnl.33.9.1109

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

Review 1.  Investigation of muscle disease.

Authors:  F L Mastaglia; N G Laing
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-03       Impact factor: 10.154

2.  Muscle fiber degeneration in distal myopathy with rimmed vacuole formation.

Authors:  N Murakami; Y Ihara; I Nonaka
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

3.  Inclusion body myositis: a case with associated collagen vascular disease responding to treatment.

Authors:  R J Lane; J J Fulthorpe; P Hudgson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-03       Impact factor: 10.154

4.  The role of quantitative electromyography in inclusion body myositis.

Authors:  T H Brannagan; A P Hays; D J Lange; W Trojaborg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-12       Impact factor: 10.154

5.  Inflammatory and non-inflammatory inclusion body myositis. Characterization of the mononuclear cells and expression of the immunoreactive class I major histocompatibility complex product.

Authors:  D Figarella-Branger; J F Pellissier; N Bianco; B Devictor; M Toga
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

6.  Inclusion body myositis with abundant ring fibers.

Authors:  M R Del Bigio; V Jay
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

7.  Transgenic mice over-expressing the C-99 fragment of betaPP with an alpha-secretase site mutation develop a myopathy similar to human inclusion body myositis.

Authors:  L W Jin; M G Hearn; C E Ogburn; N Dang; D Nochlin; W C Ladiges; G M Martin
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

8.  Inclusion body myositis: clinical and histopathological features of 36 patients.

Authors:  S Beyenburg; S Zierz; F Jerusalem
Journal:  Clin Investig       Date:  1993-05

9.  Dysphagia in inclusion body myositis.

Authors:  A R Wintzen; G T Bots; H M de Bakker; J H Hulshof; G W Padberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-12       Impact factor: 10.154

Review 10.  Autoimmune Myopathies: Updates on Evaluation and Treatment.

Authors:  Emer R McGrath; Christopher T Doughty; Anthony A Amato
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.